查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828119

2025年葡萄糖生物感测器全球市场报告

Glucose Biosensors Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，葡萄糖生物感测器市场规模强劲成长，从2024年的152.6亿美元成长到2025年的167.2亿美元，复合年增长率为9.6%。过去一段时间的成长可归因于研发、成本效益、使用者友善设计、糖尿病盛行率的上升、与智慧型装置的整合以及非侵入式监测技术。

预计未来几年，葡萄糖生物感测器市场将快速成长，到2029年将达到271.5亿美元，复合年增长率为12.9%。预测期内的成长可归因于个人化医疗解决方案、糖尿病盛行率上升、持续血糖监测的普及、与穿戴式技术的整合以及非侵入性监测技术的发展。预测期内的主要趋势包括环保生物感测器设计、互联互通和资料共用、增强型家庭医疗保健、非侵入性监测技术以及可植入生物感测器。

葡萄糖生物感测器是一种专门用于测量各种样本中血糖浓度的装置，这些样本通常存在于血液和组织液等生物体液中。葡萄糖生物感测器在医疗保健领域有着广泛的应用，尤其是在糖尿病管理领域，可以方便、频繁地监测血糖值。

葡萄糖生物感测器的主要产品类别包括持续血糖监测、自我管理血糖监测和非侵入性血糖监测。持续血糖监测 (CGM) 使用植入皮下的小型感测器来测量患者的内部血糖浓度。与标准的指尖血糖监测相比，这种方法可以更全面地了解血糖浓度并提供即时结果。主要使用的技术包括电化学生物感测器、光学生物感测器和压电感测器。这些生物感测器用于各种终端使用者应用，包括医院、居家医疗、诊断中心和诊所。

2025年春季美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供葡萄糖生物感测器市场统计数据，例如全球市场规模、各地区市场份额、各竞争对手的市场份额、详细的葡萄糖生物感测器细分市场、市场趋势和商机，以及您在葡萄糖生物感测器行业取得成功所需的数据。本葡萄糖生物感测器市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的全方位观点。

未来五年的预测成长率为12.9%，较我们先前对该市场的预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。这可能会直接影响美国，因为美国对来自丹麦和新加坡等主要地区的酵素涂层电极和连续血糖监测感测器征收关税，从而导致血糖监测准确度降低，糖尿病技术成本上升。此外，由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

预计糖尿病盛行率的上升将在未来几年推动葡萄糖生物感测器市场的成长。糖尿病是一种由胰臟胰岛素分泌不足或身体无法有效利用分泌的胰岛素所引起的慢性疾病。透过利用葡萄糖生物感测器定期监测血糖值，糖尿病患者可以更有效地管理病情并根据需要调整药物。例如，2024 年 6 月，英国管理机构 NHS England 报告称，2023 年在其全科医生处登记的 3,615,330 人被确诊患有非糖尿病性高血糖症（俗称糖尿病前期），比 2022 年的 3,065,825 人增加了近 18%。因此，糖尿病盛行率的上升是推动葡萄糖生物感测器市场扩张的关键因素。

预计老龄化人口的增加将有助于葡萄糖生物感测器市场的成长。在老年人口比例不断增加的老龄化社会中，葡萄糖生物感测器有利于透过早期发现、远端监控和全面的健康管理来支持有效的糖尿病管理。根据世界卫生组织（WHO）2022年10月的报告，到2030年，全球整体六分之一的人将年龄在60岁或以上，到2050年这个年龄层的人口将达到21亿人。在英国，英国国会下议院图书馆于2021年6月发布的预测显示，到2043年，老年人将占总人口的24%，达到1740万人。因此，老龄化人口的增加是推动葡萄糖生物感测器市场成长的关键因素。

葡萄糖生物感测器市场的主要企业正致力于推出创新产品来支援糖尿病患者，尤其是血糖监测系统。这些系统旨在持续测量血糖值并提供即时数据，帮助患者更有效地管理病情。例如，美国生技公司 DexCom Inc. 于 2024 年 10 月宣布推出 Stelo 葡萄糖生物感测器系统。该系统因成为美国食品药物管理局(FDA)核准的首个非处方 (OTC) 连续血糖监测仪 (CGM) 而闻名。 Stelo 系统适用于 18 岁及以上未使用胰岛素的成年人，包括第 2 型糖尿病患者或糖尿病前期患者。非糖尿病患者也可以使用它来监测血糖浓度，以便更好地了解饮食和运动对血糖值的影响。

为了丰富产品系列併扩大市场范围，葡萄糖生物感测器市场的主要企业正专注于推出创新产品，例如 GlucoMen Day 连续血糖监测 (CGM) 系统。 GlucoMen Day CGM 系统是一种即时皮下连续血糖监测系统，旨在帮助糖尿病患者有效管理血糖值。该系统为追踪血糖波动的传统指摘方法提供了一种更方便、更准确的替代方法。 2022 年 4 月，匈牙利医疗设备製造商 77 Elektronika Kft. 与义大利诊断公司 A. Menarini Diagnostics 合作推出了 GlucoMen Day 连续血糖监测 (CGM) 系统。 GlucoMen Day CGM 系统是糖尿病管理技术的一项显着进步，为使用者提供有关血糖浓度的宝贵见解，并使他们能够做出明智的决定，以更好地控製糖尿病。这种创新系统有可能改善糖尿病患者的生活品质并减轻这种慢性病的负担。

2023年5月，总部位于爱尔兰的医疗设备製造商Medtronic）以7.38亿美元完成对EOFLOW的收购。透过此次策略收购，Medtronic旨在拓展治疗选择，满足谨慎给药的需求，并巩固其市场地位。 EOFLOW株式会社是一家韩国医疗设备製造商，专门从事穿戴式药物输送系统的开发和製造。

葡萄糖生物感测器市场的主要参与企业包括雅培实验室、DexCom Inc.、F. Hoffmann-La Roche AG、GlySens Incorporated、Trividia Health、拜耳公司、LifeScan Inc.、美敦力公司、Nova Biomedical Corporation、Senseonics Holdings、ACON Laboratories Inc.、AMMatrix Inc.、AwConet. Inc.、杜邦公司、Biosensors International Group Ltd.、Cytiva、Universal Biosensors Inc.、CARDEA BIO INC.、Conductive Technologies Inc.、EarlySense Inc.、Innovative Sensor Technology IST AG、LifeSignals Inc.、NeuroSky Inc.、SD Biosensor INC.、Xdocsenio 和 Taidoc Technology。

2024年葡萄糖生物感测器市场最大的地区是北美。葡萄糖生物感测器市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美、中东和非洲。

葡萄糖生物感测器市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙

葡萄糖生物感测器市场涵盖磁性生物感测器、温度生物感测器、电位感测器、安培感测器和电导率感测器的销售。该市场的价值指的是“出厂价”，即产品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场的产品价值还包括产品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球葡萄糖生物感测器：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球葡萄糖生物感测器市场：成长率分析
  • 全球葡萄糖生物感测器市场表现：规模与成长，2019-2024
  • 全球葡萄糖生物感测器市场预测：规模与成长，2024-2029年，2034年
  • 全球葡萄糖生物感测器：总目标市场（TAM）

第六章 市场细分

  • 全球葡萄糖生物感测器市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 持续血糖监测（CGM）
  • 自我血糖监测（SMBG）
  • 非侵入性血糖监测
  • 全球葡萄糖生物感测器市场技术、性能及预测（2019-2024、2024-2029、2034）
  • 电化学生物感测器
  • 光学生物感测器
  • 压电生物感测器
  • 其他的
  • 全球葡萄糖生物感测器市场终端用户、效能及预测（2019-2024、2024-2029、2034）
  • 医院
  • 居家医疗
  • 诊断中心和诊所
  • 其他的
  • 全球葡萄糖生物感测器市场：连续血糖监测 (CGM) 细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 即时CGM系统
  • 专业CGM系统
  • 胰岛素帮浦集成
  • 感测器类型
  • 全球葡萄糖生物感测器市场：自我血糖监测（SMBG）细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 血糖仪
  • 测试条
  • 血液样本类型
  • 全球葡萄糖生物感测器市场：非侵入式葡萄糖监测细分市场、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 光学葡萄糖感测器
  • 经皮感应器
  • 穿戴式装置

第七章 区域和国家分析

  • 全球葡萄糖生物感测器市场：2019-2024 年、2024-2029 年和 2034 年区域表现和预测
  • 全球葡萄糖生物感测器市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 葡萄糖生物感测器市场：竞争格局
  • 葡萄糖生物感测器市场：公司简介
    • Abbott Laboratories
    • DexCom Inc.
    • F. Hoffmann-La Roche AG
    • GlySens Incorporated
    • Trividia Health

第31章：其他领先和创新企业

  • Bayer AG
  • LifeScan Inc.
  • Medtronic plc
  • Nova Biomedical Corporation
  • Senseonics Holdings
  • ACON Laboratories Inc.
  • AgaMatrix Inc.
  • Ypsomed AG
  • Ascencia Diabetes Care Holdings Inc.
  • Bio-Rad Laboratories Inc.
  • DuPont de Nemours Inc.
  • Biosensors International Group Ltd.
  • Cytiva
  • Universal Biosensors Inc.
  • CARDEA BIO INC.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年葡萄糖生物感测器市场：提供新机会的国家
  • 2029年葡萄糖生物感测器市场：细分市场将带来新机会
  • 2029年葡萄糖生物感测器市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24169u

A glucose biosensor is a specialized device designed for measuring glucose levels in different samples, commonly found in biological fluids such as blood or interstitial fluid. Widely applied in healthcare, especially for diabetes management, these biosensors facilitate convenient and frequent monitoring of blood glucose levels.

The primary product categories for glucose biosensors include continuous glucose monitoring, self-monitoring blood glucose, and non-invasive glucose monitoring. Continuous glucose monitoring (CGM) involves using a miniature sensor implanted under the skin to measure glucose levels in the patient's body. This method offers a more comprehensive view of glucose levels compared to standard fingerstick glucose monitoring and provides real-time results. The technologies predominantly used are electrochemical biosensors, optical biosensors, piezoelectric biosensors, and others. These biosensors find applications across various end-users such as hospitals, home care, diagnostic centers, clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The glucose biosensors market research report is one of a series of new reports from The Business Research Company that provides glucose biosensors market statistics, including glucose biosensors industry global market size, regional shares, competitors with a glucose biosensors market share, detailed glucose biosensors market segments, market trends and opportunities, and any further data you may need to thrive in the glucose biosensors industry. This glucose biosensors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glucose biosensors market size has grown strongly in recent years. It will grow from $15.26 billion in 2024 to $16.72 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to research and development, cost-efficiency, user-friendly design, increasing diabetes prevalence, integration with smart devices, non-invasive monitoring techniques.

The glucose biosensors market size is expected to see rapid growth in the next few years. It will grow to $27.15 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to personalized healthcare solutions, rise in diabetes cases, continuous glucose monitoring expansion, integration with wearable tech, non-invasive monitoring development. Major trends in the forecast period include eco-friendly biosensor designs, interconnectivity and data sharing, home healthcare empowerment, non-invasive monitoring techniques, implantable biosensors.

The forecast of 12.9% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on enzyme-coated electrodes and continuous glucose monitoring transmitters, sourced from key regions such as Denmark and Singapore, which could lead to compromised glycemic monitoring accuracy and increased costs for diabetes technology.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of diabetes is projected to drive the growth of the glucose biosensors market in the coming years. Diabetes is a chronic condition that occurs when the pancreas does not produce sufficient insulin or when the body is unable to effectively use the insulin produced. Patients with diabetes rely on glucose biosensors to regularly monitor their blood glucose levels, allowing them to manage their condition more effectively and adjust their medication as needed. For example, in June 2024, NHS England, a governing body in the UK, reported that in 2023, 3,615,330 individuals registered with a GP were identified as having non-diabetic hyperglycemia, commonly known as pre-diabetes, which reflects an increase from 3,065,825 in 2022-an almost 18% rise. Therefore, the growing prevalence of diabetes is a significant factor driving the expansion of the glucose biosensors market.

The increasing aging population is anticipated to contribute to the growth of the glucose biosensor market. The aging population, characterized by a rising proportion of elderly individuals, benefits from glucose biosensors that support effective diabetes management through early detection, remote monitoring, and overall well-being. According to the World Health Organization's October 2022 report, globally, one in six people will be 60 or older by 2030, with the number of individuals in this age group reaching 2.1 billion by 2050. In the United Kingdom, projections from the UK Parliament's House of Commons Library in June 2021 indicate that by 2043, the senior population will constitute 24% of the total population, amounting to 17.4 million people. Therefore, the growing aging population is a significant factor driving the growth of the glucose biosensor market.

Leading companies in the glucose biosensor market are concentrating on innovative product launches, particularly glucose monitoring systems, to assist individuals with diabetes. These systems are designed to continuously measure and provide real-time data on blood glucose levels, helping individuals manage their condition more effectively. For instance, in October 2024, DexCom Inc., a biotechnology company based in the United States, introduced the Stelo Glucose Biosensor System. This system is notable for being the first over-the-counter (OTC) continuous glucose monitor (CGM) approved by the U.S. Food and Drug Administration (FDA). The Stelo system is intended for adults aged 18 and older who do not use insulin, including those with Type 2 diabetes or prediabetes. It can also be utilized by individuals without diabetes who want to monitor their glucose levels to better understand how their diet and exercise impact blood sugar.

Major companies in the glucose biosensor market are emphasizing innovative product launches, exemplified by the introduction of the GlucoMen Day continuous glucose monitoring (CGM) system, to diversify their product portfolio and broaden market outreach. The GlucoMen Day CGM system, a real-time subcutaneous continuous glucose monitoring system, is designed to assist individuals with diabetes in effectively managing their blood sugar levels. This system offers a more convenient and accurate alternative for tracking glucose fluctuations compared to traditional finger-pricking methods. In April 2022, 77 Elektronika Kft., a Hungary-based medical equipment manufacturer, introduced the glucomen day continuous glucose monitoring (CGM) system in collaboration with A. Menarini Diagnostics, an Italy-based diagnostics company. The glucomen day CGM system represents a notable advancement in diabetes management technology, providing users with valuable insights into their glucose levels and empowering them to make informed decisions for better diabetes control. This innovative system has the potential to enhance the quality of life for people with diabetes and alleviate the burden of this chronic condition.

In May 2023, Medtronic plc, an Ireland-based medical device company, completed the acquisition of EOFLOW Co., Ltd. for $738 million. Through this strategic acquisition, Medtronic plc aims to broaden treatment options, cater to the demand for discreet delivery, and strengthen its position in the market. EOFLOW Co. Ltd. is a South Korea-based medical device company specialized in developing and manufacturing wearable drug delivery systems.

Major companies operating in the glucose biosensors market include Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, GlySens Incorporated, Trividia Health, Bayer AG, LifeScan Inc., Medtronic plc, Nova Biomedical Corporation, Senseonics Holdings, ACON Laboratories Inc., AgaMatrix Inc., Ypsomed AG, Ascencia Diabetes Care Holdings Inc., Bio-Rad Laboratories Inc., DuPont de Nemours Inc., Biosensors International Group Ltd., Cytiva, Universal Biosensors Inc., CARDEA BIO INC., Conductive Technologies Inc., EarlySense Inc., Innovative Sensor Technology IST AG, LifeSignals Inc., NeuroSky Inc., SD Biosensor INC., Xsensio, Taidoc Technology Corporation

North America was the largest region in the glucose biosensors market in 2024. The regions covered in the glucose biosensors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the glucose biosensors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The glucose biosensors market consists of sales of magnetic biosensors, thermometric biosensors, potentiometric, amperometric, and conductometric sensors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Glucose Biosensors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glucose biosensors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glucose biosensors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The glucose biosensors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Continuous Glucose Monitoring; Self-monitoring Blood Glucose; Non-invasive Glucose Monitoring
  • 2) By Technology: Electrochemical Biosensors; Optical Biosensors; Piezoelectric Biosensors; Others Technologies
  • 3) By End Users: Hospitals; Home Care; Diagnostic Centers and Clinics; Other End Users
  • Subsegments:
  • 1) By Continuous Glucose Monitoring (CGM): Real-time CGM systems; Professional CGM systems; Integration with insulin pumps; Sensor types
  • 2) By Self-monitoring Blood Glucose (SMBG): Glucometers; Test strips; Blood sample types
  • 3) By Non-invasive Glucose Monitoring: Optical glucose sensors; Transdermal sensors; Wearable devices
  • Companies Mentioned: Abbott Laboratories; DexCom Inc.; F. Hoffmann-La Roche AG; GlySens Incorporated; Trividia Health; Bayer AG; LifeScan Inc.; Medtronic plc; Nova Biomedical Corporation; Senseonics Holdings; ACON Laboratories Inc.; AgaMatrix Inc.; Ypsomed AG; Ascencia Diabetes Care Holdings Inc.; Bio-Rad Laboratories Inc.; DuPont de Nemours Inc.; Biosensors International Group Ltd.; Cytiva; Universal Biosensors Inc.; CARDEA BIO INC.; Conductive Technologies Inc.; EarlySense Inc.; Innovative Sensor Technology IST AG; LifeSignals Inc.; NeuroSky Inc.; SD Biosensor INC.; Xsensio; Taidoc Technology Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Glucose Biosensors Market Characteristics

3. Glucose Biosensors Market Trends And Strategies

4. Glucose Biosensors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Glucose Biosensors Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Glucose Biosensors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Glucose Biosensors Market Growth Rate Analysis
  • 5.4. Global Glucose Biosensors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Glucose Biosensors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Glucose Biosensors Total Addressable Market (TAM)

6. Glucose Biosensors Market Segmentation

  • 6.1. Global Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Continuous Glucose Monitoring
  • Self-monitoring Blood Glucose
  • Non-invasive Glucose Monitoring
  • 6.2. Global Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electrochemical Biosensors
  • Optical Biosensors
  • Piezoelectric Biosensors
  • Other Technologies
  • 6.3. Global Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Home Care
  • Diagnostic Centers and Clinics
  • Other End Users
  • 6.4. Global Glucose Biosensors Market, Sub-Segmentation Of Continuous Glucose Monitoring (CGM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Real-time CGM systems
  • Professional CGM systems
  • Integration with insulin pumps
  • Sensor types
  • 6.5. Global Glucose Biosensors Market, Sub-Segmentation Of Self-monitoring Blood Glucose (SMBG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glucometers
  • Test strips
  • Blood sample types
  • 6.6. Global Glucose Biosensors Market, Sub-Segmentation Of Non-invasive Glucose Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Optical glucose sensors
  • Transdermal sensors
  • Wearable devices

7. Glucose Biosensors Market Regional And Country Analysis

  • 7.1. Global Glucose Biosensors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Glucose Biosensors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Glucose Biosensors Market

  • 8.1. Asia-Pacific Glucose Biosensors Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Glucose Biosensors Market

  • 9.1. China Glucose Biosensors Market Overview
  • 9.2. China Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Glucose Biosensors Market

  • 10.1. India Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Glucose Biosensors Market

  • 11.1. Japan Glucose Biosensors Market Overview
  • 11.2. Japan Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Glucose Biosensors Market

  • 12.1. Australia Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Glucose Biosensors Market

  • 13.1. Indonesia Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Glucose Biosensors Market

  • 14.1. South Korea Glucose Biosensors Market Overview
  • 14.2. South Korea Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Glucose Biosensors Market

  • 15.1. Western Europe Glucose Biosensors Market Overview
  • 15.2. Western Europe Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Glucose Biosensors Market

  • 16.1. UK Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Glucose Biosensors Market

  • 17.1. Germany Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Glucose Biosensors Market

  • 18.1. France Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Glucose Biosensors Market

  • 19.1. Italy Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Glucose Biosensors Market

  • 20.1. Spain Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Glucose Biosensors Market

  • 21.1. Eastern Europe Glucose Biosensors Market Overview
  • 21.2. Eastern Europe Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Glucose Biosensors Market

  • 22.1. Russia Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Glucose Biosensors Market

  • 23.1. North America Glucose Biosensors Market Overview
  • 23.2. North America Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Glucose Biosensors Market

  • 24.1. USA Glucose Biosensors Market Overview
  • 24.2. USA Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Glucose Biosensors Market

  • 25.1. Canada Glucose Biosensors Market Overview
  • 25.2. Canada Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Glucose Biosensors Market

  • 26.1. South America Glucose Biosensors Market Overview
  • 26.2. South America Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Glucose Biosensors Market

  • 27.1. Brazil Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Glucose Biosensors Market

  • 28.1. Middle East Glucose Biosensors Market Overview
  • 28.2. Middle East Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Glucose Biosensors Market

  • 29.1. Africa Glucose Biosensors Market Overview
  • 29.2. Africa Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Glucose Biosensors Market Competitive Landscape And Company Profiles

  • 30.1. Glucose Biosensors Market Competitive Landscape
  • 30.2. Glucose Biosensors Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. DexCom Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GlySens Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Trividia Health Overview, Products and Services, Strategy and Financial Analysis

31. Glucose Biosensors Market Other Major And Innovative Companies

  • 31.1. Bayer AG
  • 31.2. LifeScan Inc.
  • 31.3. Medtronic plc
  • 31.4. Nova Biomedical Corporation
  • 31.5. Senseonics Holdings
  • 31.6. ACON Laboratories Inc.
  • 31.7. AgaMatrix Inc.
  • 31.8. Ypsomed AG
  • 31.9. Ascencia Diabetes Care Holdings Inc.
  • 31.10. Bio-Rad Laboratories Inc.
  • 31.11. DuPont de Nemours Inc.
  • 31.12. Biosensors International Group Ltd.
  • 31.13. Cytiva
  • 31.14. Universal Biosensors Inc.
  • 31.15. CARDEA BIO INC.

32. Global Glucose Biosensors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Glucose Biosensors Market

34. Recent Developments In The Glucose Biosensors Market

35. Glucose Biosensors Market High Potential Countries, Segments and Strategies

  • 35.1 Glucose Biosensors Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Glucose Biosensors Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Glucose Biosensors Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer